heart-rate-pulse-graph

Acute Tubular Necrosis (ATN)

Anesthesia Implications

Updated On: July 23, 2026

Anesthesia Implications

Know the two intraoperative routes in - hypotensive (low cardiac output, low MAP, aortic cross-clamp) or nephrotoxic (iodinated contrast, aminoglycosides, amphotericin B, cisplatin, acyclovir, sulfa drugs, calcineurin inhibitors such as tacrolimus and cyclosporine, sucrose-containing IVIG, rhabdomyolysis, atheroembolism). Cardiopulmonary bypass is multifactorial and hits both.

Ventilation is a renal variable - mechanical ventilation and PEEP transmit airway and intrapleural pressure to the intravascular space, dropping venous return, effective filling pressures, and cardiac output — and with them renal blood flow, GFR, sodium excretion, and urine output. Use the lowest PEEP that does the job in a kidney at risk.

Separate ATN from prerenal AKI - urine microscopy shows muddy brown granular casts and renal tubular epithelial cells in ATN versus a bland sediment or hyaline casts in prerenal disease. FENa above 2% and urine sodium above 40 to 50 mEq/L favor ATN; FENa under 1% and urine sodium under 20 mEq/L favor prerenal. Both markers are unreliable after diuretics and in heart failure or cirrhosis.

The fluid challenge is the real test - unless the clinical picture forbids it, give a fluid challenge and follow urine output and creatinine. Renal function that improves with volume was prerenal; ATN does not respond and takes weeks to months.

Hold the pressure up - hypotension, low cardiac output, and cross-clamp are the hypotensive drivers of postoperative ATN. Treat volume depletion and low output aggressively rather than chasing urine output with diuretics.

Stack no further insults - delay contrast studies, stop aminoglycosides and NSAIDs, and reconsider ACE inhibitors and ARBs, which are frequent co-contributors. Every drug the patient is on needs renal dosing once creatinine starts to rise, with levels followed for agents like vancomycin.

Watch the electrolytes in the oliguric phase - this is where hyperkalemia, metabolic acidosis, and fluid overload appear. Get a day-of potassium and bicarbonate before induction and before any succinylcholine.

Abdominal pressure counts - intraabdominal hypertension from abdominal compartment syndrome impedes renal perfusion. Keep insufflation pressures modest and flag a tight abdominal closure.

Sepsis-driven ATN - systemic hypotension, endotoxin-mediated renal vasoconstriction, and inflammatory cytokines all contribute. Source control and perfusion pressure are the renal intervention here.

Renal transplant - crystalloid volume expansion plus mannitol 12.5 to 25 g before vessel clamp is common practice and has reduced postoperative ATN in a randomized study, though kidney function at three months was no different. Mannitol also increases renal blood flow and flushes cellular debris that would otherwise form tubular casts.

Plan around dialysis - short-term renal replacement therapy is often needed until function recovers; in-hospital mortality reaches 30% to 50% when dialysis is required, and 12% to 15% of AKI patients end up on permanent dialysis. Know the last session and the dry weight before you start.

Pathophysiology

ATN is the most common intrinsic cause of acute kidney injury (AKI) and the most common form of renal failure after surgery. Tubular epithelial cells are injured and die from ischemia, direct nephrotoxicity, sepsis, or a mixture; the brush border is effaced, cells slough into the lumen, and casts obstruct flow while intrarenal vasoconstriction drops GFR. The corticomedullary junction takes the brunt of the injury.

Clinically it runs in four phases: initiation (abrupt GFR fall with rising creatinine and BUN), extension (endothelial injury and cytokine-driven inflammation in the outer medulla), maintenance (cellular repair and reorganization), and recovery. That matters perioperatively because ATN is slow — recovery takes weeks to months and may never return to baseline, and prerenal azotemia converts to ATN if the insult is prolonged.


Suggested Reading

Hemmings HC Jr, Yao FF, Goldstein PA, et al, eds. Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management. 10th ed. Wolters Kluwer; 2025.
Gropper MA, Eriksson LI, Fleisher LA, et al, eds. Miller's Anesthesia. 10th ed. Elsevier; 2024.
Hines RL, ed. Stoelting's Anesthesia and Co-Existing Disease. 8th ed. Elsevier; 2021.
Ramoutar V, Landa C, James LR. Acute tubular necrosis (ATN) presenting with an unusually prolonged period of marked polyuria heralded by an abrupt oliguric phase. BMJ Case Rep. 2014. PMID: 25150229.
Moyses Neto M, Costa RS, Volpini RA, et al. Interstitial alterations in renal cortex in acute tubular necrosis (ATN) post-renal transplantation and in patients with ATN not related to renal transplant. Clin Transplant. 2004. PMID: 15016130.
Rosen S, Heyman S. Concerns about KIM-1 as a urinary biomarker for acute tubular necrosis (ATN). Kidney Int. 2003. PMID: 12675879.